Caleb Lareau
Overview
Explore the profile of Caleb Lareau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
1510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
LaFave L, Kartha V, Ma S, Meli K, Del Priore I, Lareau C, et al.
Cancer Cell
. 2025 Mar;
PMID: 40054468
No abstract available.
2.
Yu K, Abou-Mrad Z, Torkenczy K, Schulze I, Gantchev J, Baquer G, et al.
bioRxiv
. 2025 Mar;
PMID: 40027797
Malignant gliomas follow two distinct natural histories: high grade tumors such as glioblastoma, or lower grade tumors with a propensity to transform into high grade disease. Despite differences in tumor...
3.
Nuno K, Azizi A, Koehnke T, Lareau C, Ediriwickrema A, Corces M, et al.
Elife
. 2024 Apr;
13.
PMID: 38647535
Relapse of acute myeloid leukemia (AML) is highly aggressive and often treatment refractory. We analyzed previously published AML relapse cohorts and found that 40% of relapses occur without changes in...
4.
Bucktrout S, Banovich N, Butterfield L, Cimen-Bozkus C, Giles J, Good Z, et al.
Nat Med
. 2024 Feb;
30(5):1505.
PMID: 38317023
No abstract available.
5.
Doan A, Mueller K, Chen A, Rouin G, Daniel B, Lattin J, et al.
Res Sq
. 2023 Nov;
PMID: 37986944
Poor CAR T persistence limits CAR T cell therapies for B cell malignancies and solid tumors. The expression of memory-associated genes such as (protein name TCF1) is linked to response...
6.
7.
Tousley A, Rotiroti M, Labanieh L, Rysavy L, Kim W, Lareau C, et al.
Nature
. 2023 Mar;
615(7952):507-516.
PMID: 36890224
Although chimeric antigen receptor (CAR) T cells have altered the treatment landscape for B cell malignancies, the risk of on-target, off-tumour toxicity has hampered their development for solid tumours because...
8.
Panditharatna E, Marques J, Wang T, Trissal M, Liu I, Jiang L, et al.
Cancer Discov
. 2022 Oct;
12(12):2880-2905.
PMID: 36305736
Significance: Epigenetic dysregulation is at the core of H3K27M-glioma tumorigenesis. Here, we identify the BRG1-BAF complex as a critical regulator of enhancer and transcription factor landscapes, which maintain H3K27M glioma...
9.
Bucktrout S, Banovich N, Butterfield L, Cimen-Bozkus C, Giles J, Good Z, et al.
Nat Med
. 2022 Sep;
28(9):1761-1764.
PMID: 36127419
No abstract available.
10.
King H, Wells K, Shipony Z, Kathiria A, Wagar L, Lareau C, et al.
Sci Immunol
. 2021 Oct;
6(64):eabh3768.
PMID: 34623901
The germinal center (GC) response is critical for both effective adaptive immunity and establishing peripheral tolerance by limiting autoreactive B cells. Dysfunction in these processes can lead to defective immune...